- Benign Prostatic Hyperplasia
- Hormone Therapy
- Genomic Testing
- Next-Generation Imaging
- UTUC
- OAB and Incontinence
- Genitourinary Cancers
- Kidney Cancer
- Men's Health
- Pediatrics
- Female Urology
- Sexual Dysfunction
- Kidney Stones
- Urologic Surgery
- Bladder Cancer
- Benign Conditions
- Prostate Cancer
Future research directions following study of UTI rates in transgender women post-vaginoplasty
"We did discuss a couple of future research ideas, a number of which would have been controlling for those potential factors we thought could contribute to the increased UTI risk that we were not able to control for in the study like loss of commensal bacteria or anything of that nature," says David Gilbert.
In this video, David Gilbert discusses potential future research directions following the recent Urology paper, “Rates of UTI in Transgender Women Post-Vaginoplasty versus Cisgender Women: A Retrospective Cohort Study in a Large US Health Network.” Gilbert is an MD candidate at Case Western Reserve University School of Medicine in Cleveland, Ohio.
Transcription:
Does your paper address any potential future research directions; for example, investigating preventive measures to reduce UTI risk in transgender women post surgery?
We did discuss a couple of future research ideas, a number of which would have been controlling for those potential factors we thought could contribute to the increased UTI risk that we were not able to control for in the study like loss of commensal bacteria or anything of that nature. Something that would be possibly preventative is one of the theories we had for the increased UTI risk was introduction of non native bacteria through the use of dilators or douching, which are required for maintenance of the neovagina. So there could be something done on the provider end to ensure sterility of those tools.
Did your study look at any other potential outcomes besides UTIs following vaginoplasty in transgender women compared with cisgender women?
Our study did not; it was a lot of data to get through, so we tried to keep it where it was. But our lab as a whole has been exploring other outcomes post vaginoplasty. We have a paper that I think is still being written but was just presented at a few conferences exploring STI rates in trans women vs cis women post vaginoplasty, which can be pretty interesting because some of them have a predilection for vaginal epithelium. And so having a different tissue in the neovagina could influence those rates pretty interestingly.
This transcription was edited for clarity.
Destigmatizing Urology: Dr. Winter discusses STDs/STIs
March 22nd 2022“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.
Burden of care for recurrent UTI is higher for female urologists
June 15th 2024"What we believe is happening is women are seeking the help of female urologists, and therefore, because of the nature of the condition, the female urologists are absorbing the burden of the care of these patients, particularly the non-billable burden," says Debra L. Fromer, MD.
Predictive model quantifies risk of antibiotic resistance in uUTI
May 24th 2024The predictive models identified the number of previous UTI episodes, prior β-lactam nonsusceptibility, prior fluoroquinolone treatment, Census Bureau region (particularly in the South), and race as key predictors of having a non-susceptible isolate to 3 or more antibiotic classes.
